Related Experiment Videos
[Vitreoretinal surgery in diabetic patients in a dialysis program].
1Ocní klinika Fakultní nemocnice U svaté Anny, Brno.
Summary
Pars plana vitrectomy is feasible in patients with severe renal and retinal conditions, improving quality of life for half. Careful anticoagulant selection minimizes risks, but further trials are needed for silicon oil tamponade effectiveness.
Area of Science:
- Ophthalmology
- Nephrology
- Vascular Surgery
Background:
- Pars plana vitrectomy was historically a contraindication in patients with severe renal and retinal diseases.
- These complex cases present significant surgical risks.
Purpose of the Study:
- To evaluate the feasibility and outcomes of pars plana vitrectomy in patients with severe renal and retinal affections.
- To assess the impact on quality of life and identify risk mitigation strategies.
Main Methods:
- Retrospective analysis of patients undergoing pars plana vitrectomy with severe renal and retinal conditions.
- Evaluation of visual acuity, operative complications, and postoperative outcomes.
- Analysis of anticoagulant selection and its impact on peroperative and postoperative events.
Main Results:
- Pars plana vitrectomy is possible in this patient cohort, despite some cases experiencing visual acuity deterioration.
- Approximately 50% of patients reported an improved quality of life post-surgery.
- Appropriate anticoagulant selection appears to reduce surgical risks.
Conclusions:
- Pars plana vitrectomy can be considered in patients with severe renal and retinal diseases, with potential for improved quality of life.
- Careful management of anticoagulation is crucial for minimizing complications.
- Further controlled trials are warranted to investigate the benefits of silicon oil tamponade in the postoperative course.